
Kerstin Folkerts, MSc
Advertisement
Articles by Kerstin Folkerts, MSc
Advertisement
Latest Updated Articles
Targeted Literature Review of the Burden of Illness in Patients With Chronic Kidney Disease and Type 2 DiabetesPublished: May 11th 2021 | Updated:
ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney DiseasePublished: December 8th 2021 | Updated:
eAppendix: FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 DiabetesPublished: December 8th 2021 | Updated:
eAppendix: ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney DiseasePublished: December 8th 2021 | Updated:
FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 DiabetesPublished: December 8th 2021 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Sibeprenlimab for Immunoglobulin A Nephropathy
2
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
3
Faricimab Brought Early Control of Some Symptoms in AMD
4
Patients Face New Care Complexities as DTC Options Expand
5



